Abstract

The food supplement glucosamine has been claimed to modify progression of osteoarthritis1 and is being extensively marketed as a treatment for patients with the condition. In fact, the UK annual market for glucosamine is now estimated to be over £10 million.2 Here, we examine whether the supplement has a place in the management of osteoarthritis.